Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesEffectively discussing complementary and alternative medicine in a conventional oncology setting: Communication recommendations for clinicians
Patient Education and Counselling, 09/29/09
Schofield P et al. – This represents the first comprehensive guidelines for discussing CAM. Given the concerns surrounding CAM use, it is critical to encourage informed decision–making about CAM and ultimately, improve outcomes for patients.
Methods- A systematic review was conducted, covering relevant literature from 1997 to 2007.
- The level of evidence was rated using a standardized rating system.
- The evidence was qualitatively synthesised into structured recommendations by a multidisciplinary team including a consumer.
- The search identified 78 original papers; 36 directly related to discussing CAM.
- No randomized controlled trials specifically addressing the methods or benefits of discussing CAM were identified.
- Evidence based guidelines are presented as a sequence of recommended steps: (1) Elicit the person's understanding of their situation; (2) Respect cultural and linguistic diversity and different epistemological frameworks; (3) Ask questions about CAM use at critical points in the illness trajectory; (4) Explore details and actively listen; (5) Respond to the person's emotional state; (6) Discuss relevant concerns while respecting the person's beliefs; (7) Provide balanced, evidence–based advice; (8) Summarize discussions; (9) Document the discussion; (10) Monitor and follow–up.
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions
Cancer Prevention Research, 11/09/09
Oral Cancer Prevention Advances with a Translational Trial of Green Tea
Cancer Prevention Research, 11/11/09
Sponsor
Article Search
Sponsor
Sponsor